As researchers look for ways to reduce the need for animals in their studies, new alternative methods (NAMs) are an intriguing route to capture crucial safety data and help advance drug discovery and development – specifically, virtual control groups (VCGs).  

Join Steve Bulera, CVP and Chief Scientific Officer for Safety Assessment and Toxicology at Charles River, as he discusses how VCGs can be a viable alternative to research models, what it would take for the industry to widely accept NAMs, and how they can revolutionize research for the future.

Show Notes

Virtual Control Groups  

Sounds of Science E73: Virtual Control Groups 

Modernizing Drug Development with Virtual Control Groups 

Virtual Control Groups: A Data-Driven Novel Method 

Revolutionizing the Future of Safety Studies 

Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals